Dr. Quinn on Current State of Biomarkers in RCC

Video

In Partnership With:

David I. Quinn, MD, PhD, associate professor of medicine, section head, Genitourinary Oncology, Division of Cancer Medicine and Blood Diseases, Keck School of Medicine, discusses the current state of biomarkers in renal cell carcinoma.

David I. Quinn, MD, associate professor of medicine, section head, Genitourinary Oncology, Division of Cancer Medicine and Blood Diseases in the Department of Medicine, Keck School of Medicine, discusses current biomarkers in renal cell carcinoma (RCC).

At the moment, the field is not doing very well in this aspect, Quinn says. Ideally, researchers would have to identify a certain biomarker such as PD-L1 expression in the tumor microenvironment or infiltrating immune cells before giving a therapy. However, there’s still a long way to go with this research in RCC. Right now, if oncologists have to choose between utilizing a biomarker or not, they usually won’t unless there is proven benefit in doing so, Quinn admits.

However, recent studies of different combinations of immunotherapies and VEGF TKIs suggest that there may be certain gene signatures in patients that may indicate who will do well with each therapy. Better understanding of these signatures may help researchers overcome intrinsic resistance, Quinn adds; however, this is just postulation at this stage and confirmatory research is needed.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD